Lonza's CEO on keeping up with microbiome, gene therapy boom

Lonza's CEO on keeping up with microbiome, gene therapy boom

Source: 
Biopharma Dive
snippet: 

Marc Funk told BioPharma Dive manufacturing has been an obstacle for microbiome drugmakers, something the Swiss CDMO hopes to solve with a new JV.